DrugDashboards

Market view

rufinamide · Suspension

10 marketed package NDCs · 10 active manufacturers

Most dispensed: 40 mg/mL · Suspension · #1 bottle/carton / 460 ml in 1 bottle · 400 mg · Tablet, Film Coated · #120 tablet, film coateds/bottle · 200 mg · Tablet, Film Coated · #120 tablet, film coateds/bottle · 400 mg · Tablet · #120 tablets/bottle

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. The generic price has fallen 45% in a year, to $0.2036 per mL — and generics that get this cheap tend to get abandoned rather than defended. The brand runs $3.65 per mL 18× more.

Price range and competition

RSS: changes for this drug
priced separately — they are not the same market

Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$2.00$4.00Jan 2021Sep 2026010companies actively selling

Latest · Sep 2026 — typical price $0.2036 · middle half $0.2036$0.2036 · full range $0.2036$0.2036 · 8 products · 10 companies

middle half of companies’ pricestypical (median) pricewhat manufacturers charge wholesalers (WAMP)companies actively selling (bottom lane)Priced per mLSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for rufinamide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • RufinamideAug 19, 2026
    Price up
    NADAC $0.20212 → $0.20359 per unit (+0.73%)
  • RufinamideAug 19, 2026
    Price up
    NADAC $0.20212 → $0.20359 per unit (+0.73%)
  • RufinamideAug 19, 2026
    Price up
    NADAC $0.20212 → $0.20359 per unit (+0.73%)
  • rufinamideAug 19, 2026
    Price up
    NADAC $1.4126 → $1.45319 per unit (+2.87%)
  • rufinamideAug 19, 2026
    Price down
    NADAC $0.85264 → $0.83197 per unit (-2.42%)
  • RufinamideAug 19, 2026
    Price up
    NADAC $1.4126 → $1.45319 per unit (+2.87%)
  • RufinamideAug 19, 2026
    Price down
    NADAC $0.85264 → $0.83197 per unit (-2.42%)
  • RufinamideAug 19, 2026
    Price up
    NADAC $0.20212 → $0.20359 per unit (+0.73%)
  • RufinamideAug 19, 2026
    Price up
    NADAC $0.20212 → $0.20359 per unit (+0.73%)
  • BanzelAug 19, 2026
    Price up
    NADAC $3.64815 → $3.64862 per unit (+0.01%)

Common questions

Is Rufinamide in shortage right now?
No. FDA does not currently list Rufinamide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Rufinamide?
20 companies have marketed Rufinamide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Rufinamide cost?
The typical pharmacy pays about $0.8320 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.